We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Accept Cookies
Vildagliptin is a DPP-4 inhibitor approved for the treatment of type 2 diabetes. Glucagon-like peptide-1 (GLP-1) is a hormone that is rapidly released from the intestine after eating. GLP-1 signals to the pancreas to increase insulin release, and reduce glucagon release, after a meal.
Metformin hydrochloride decreases the amount of glucose (a type of sugar) released into the bloodstream from the liver and increases the body's use of the glucose.
We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy